AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8204940 — intervention group
Group type: EXPERIMENTAL
Intervention: IL2 as a continuous infusion or high doses intravenous IL2 combined with alpha interferon (IFN) or a combination of IL2 and IFN as subcutaneous low doses
Number of subjects: 244
Study 8204940 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IL2 with Tumor Necrosis Factor (TNF) as rescue treatment
Number of subjects: 244
Study 8204940 — intervention group
Group type: EXPERIMENTAL
Intervention: Most intensive regimen of IL2 and IFN
Number of subjects: 244
Study 3961002 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg hydrocortisone
Number of subjects: 80
Study 3961002 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone
Number of subjects: 80
Study 3961002 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg hydrocortisone
Number of subjects: 80
Study 3961002 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg hydrocortisone
Number of subjects: 80
Study 3961002 — intervention group
Group type: COMPARATOR
Intervention: Glucose (control)
Number of subjects: 80
Study 31393917 — intervention group
Group type: EXPERIMENTAL
Intervention: Pride induction
Number of subjects: 477
Study 31393917 — intervention group
Group type: COMPARATOR
Intervention: Awe induction
Number of subjects: 477
Study 31393917 — intervention group
Group type: COMPARATOR
Intervention: Neutral emotion induction
Number of subjects: 477
Study 31393917 — intervention group
Group type: EXPERIMENTAL
Intervention: Pride induction (Study 2)
Number of subjects: 477
Study 31393917 — intervention group
Group type: EXPERIMENTAL
Intervention: Pride induction (Study 3)
Number of subjects: 477
Study 27091835 — intervention group
Group type: EXPERIMENTAL
Intervention: Glargine insulin
Number of subjects: 67
Study 27091835 — intervention group
Group type: COMPARATOR
Intervention: RI-in-PN (Regular Insulin in Parenteral Nutrition)
Number of subjects: 67
Study 26476506 — intervention group
Group type: EXPERIMENTAL
Intervention: hsTnI measurement followed by advanced coronary CTA assessment
Number of subjects: 160
Study 26476506 — intervention group
Group type: COMPARATOR
Intervention: Conventional troponin measurement and traditional coronary CTA assessment
Number of subjects: 160
Study 23642372 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal laser photocoagulation plus intravitreal ranibizumab (L+R)
Number of subjects: 1
Study 23642372 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal laser photocoagulation plus intravitreal bevacizumab (L+B)
Number of subjects: 1
Study 23642372 — intervention group
Group type: COMPARATOR
Intervention: Focal laser photocoagulation (L)
Number of subjects: 1
Study 23642372 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal laser photocoagulation plus intravitreal triamcinolone (L+T)
Number of subjects: 1
Study 21346758 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent administration of oral deuterated alfentanil and intravenous unlabeled alfentanil
Number of subjects: 0
Study 21346758 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential dosing of alfentanil
Number of subjects: 0
Study 21346758 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous dosing of alfentanil
Number of subjects: 0
Study 21346758 — intervention group
Group type: COMPARATOR
Intervention: Rifampin, ketoconazole, and grapefruit juice (as inducers/inhibitors)
Number of subjects: 0
Study 19451297 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir (LPV/r) monotherapy
Number of subjects: 121
Study 19451297 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir-ritonavir (LPV/r) plus zidovudine and lamivudine triple therapy
Number of subjects: 121
Study 16423847 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Number of subjects: 164
Study 16423847 — intervention group
Group type: COMPARATOR
Intervention: Anthracycline alone (Control)
Number of subjects: 164
Study 15503072 — intervention group
Group type: EXPERIMENTAL
Intervention: Recalled mother‐child relationship
Number of subjects: 737
Study 15503072 — intervention group
Group type: EXPERIMENTAL
Intervention: Recalled father‐child relationship
Number of subjects: 737
Study 15503072 — intervention group
Group type: EXPERIMENTAL
Intervention: Openness
Number of subjects: 737
Study 15503072 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreeableness
Number of subjects: 737
Study 10924375 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer assay
Number of subjects: 143
Study 10924375 — intervention group
Group type: COMPARATOR
Intervention: D-dimer assay (negative results)
Number of subjects: 143
Study 8975246 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured asthma education with subsequent training course of 6 months' duration
Number of subjects: 0
Study 8975246 — intervention group
Group type: COMPARATOR
Intervention: Control group (no subsequent training)
Number of subjects: 0
Study 1563557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical application of highly viscous prostaglandin E2 (PGE2) gel
Number of subjects: 138
Study 1563557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 3907288 — intervention group
Group type: EXPERIMENTAL
Intervention: Toluene exposure (382 mg/m3 for 6 1/2 hours)
Number of subjects: 86
Study 3907288 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched male controls)
Number of subjects: 86
Study 3089466 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion of egg and cows' milk by mothers in a double blind crossover trial.
Number of subjects: 37
Study 3089466 — intervention group
Group type: EXPERIMENTAL
Intervention: Open exclusion of 11 foods followed by double blind challenge.
Number of subjects: 37
Study 31146640 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian Mendelian randomization approach (BayesMR)
Number of subjects: 0
Study 31146640 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian model averaging
Number of subjects: 0
Study 30256758 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperate water (24-25 °C)
Number of subjects: 13
Study 30256758 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water (36.5-37.5 °C)
Number of subjects: 13
Study 30256758 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water (16.5-17.5 °C)
Number of subjects: 13
Study 29146657 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoBarrier device for 12 months
Number of subjects: 160
Study 29146657 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy, diet and exercise for 12 months
Number of subjects: 160
Study 25425736 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit to alz.org (experimental group)
Number of subjects: 552
Study 25425736 — intervention group
Group type: COMPARATOR
Intervention: No visit to a web site (control group)
Number of subjects: 552
Study 22868828 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating Index (HEI) assessment at study entry (10-20 weeks gestation)
Number of subjects: 301
Study 22868828 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating Index (HEI) assessment at 28 weeks gestation
Number of subjects: 301
Study 22868828 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating Index (HEI) assessment at 36 weeks gestation
Number of subjects: 301
Study 22868828 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating Index (HEI) assessment at 4 months post-partum
Number of subjects: 301
Study 22868828 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary component analysis (milk, meat, unsaturated oil)
Number of subjects: 301
Study 22868828 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic index for areas score
Number of subjects: 301
Study 21996765 — intervention group
Group type: EXPERIMENTAL
Intervention: Forest environment
Number of subjects: 48
Study 21996765 — intervention group
Group type: COMPARATOR
Intervention: Urban environment
Number of subjects: 48
Study 19055199 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI 160/4.5 microg x 2 inhalations (320/9 microg)
Number of subjects: 596
Study 19055199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 596
Study 17156651 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin ER 500 mg/d for 4 weeks and then 1000 mg/d for 4 weeks
Number of subjects: 110
Study 17156651 — intervention group
Group type: EXPERIMENTAL
Intervention: atorvastatin 10 mg/d for 8 weeks
Number of subjects: 110
Study 17156651 — intervention group
Group type: EXPERIMENTAL
Intervention: atorvastatin (10 mg/d) plus niacin ER (starting from 500 mg/d to 1000 mg/d after 4 weeks) for 8 weeks
Number of subjects: 110
Study 17156651 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy
Number of subjects: 110
Study 17156651 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin ER
Number of subjects: 110
Study 14560221 — intervention group
Group type: EXPERIMENTAL
Intervention: StO2 measurement in PAD patients during and after exercise
Number of subjects: 49
Study 14560221 — intervention group
Group type: COMPARATOR
Intervention: StO2 measurement in normal subjects during and after exercise
Number of subjects: 49
Study 10902985 — intervention group
Group type: EXPERIMENTAL
Intervention: Community vaccination programs
Number of subjects: 415
Study 10902985 — intervention group
Group type: EXPERIMENTAL
Intervention: Child care services
Number of subjects: 415
Study 10902985 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental sanitation
Number of subjects: 415
Study 10902985 — intervention group
Group type: EXPERIMENTAL
Intervention: Latrines
Number of subjects: 415
Study 9363305 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon-impregnated PTFE graft
Number of subjects: 160
Study 9363305 — intervention group
Group type: COMPARATOR
Intervention: Standard PTFE graft
Number of subjects: 160
Study 1401694 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone 2 mg/kg
Number of subjects: 29
Study 1401694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 3908352 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (200 mg daily)
Number of subjects: 41
Study 3908352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 31407856 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 4533
Study 31407856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4533
Study 27242010 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene with sterile water (SG)
Number of subjects: 37
Study 27242010 — intervention group
Group type: COMPARATOR
Intervention: No intervention (CG)
Number of subjects: 37
Study 26369484 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal therapy (scaling and root planning)
Number of subjects: 100
Study 26369484 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 100
Study 23230109 — intervention group
Group type: EXPERIMENTAL
Intervention: MP21-50
Number of subjects: 66
Study 23230109 — intervention group
Group type: EXPERIMENTAL
Intervention: AdP50-140
Number of subjects: 66
Study 23230109 — intervention group
Group type: EXPERIMENTAL
Intervention: AdP21-50
Number of subjects: 66
Study 23230109 — intervention group
Group type: COMPARATOR
Intervention: MP50-140
Number of subjects: 66
Study 21259024 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-PRO (18 g L(‐1) PRO, 72 g L(‐1) CHO)
Number of subjects: 28
Study 21259024 — intervention group
Group type: COMPARATOR
Intervention: PLA (76 g L(‐1) CHO)
Number of subjects: 28
Study 19038426 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormadinone (steroidal antiandrogen)
Number of subjects: 151
Study 19038426 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide (nonsteroidal antiandrogen)
Number of subjects: 151
Study 19038426 — intervention group
Group type: COMPARATOR
Intervention: Functional Assessment of Cancer Therapy‐Prostate scores
Number of subjects: 151
Study 17868802 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 1012
Study 17868802 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1012
Study 15056094 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation (PCS) with propofol
Number of subjects: 114
Study 15056094 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered propofol sedation (NAPS)
Number of subjects: 114
Study 15056094 — intervention group
Group type: COMPARATOR
Intervention: Standard nurse-sedated control group
Number of subjects: 114
Study 11589384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of physiological dose of PYY
Number of subjects: 8
Study 9835672 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiVent
Number of subjects: 7
Study 9835672 — intervention group
Group type: COMPARATOR
Intervention: ACE
Number of subjects: 7
Study 7651811 — intervention group
Group type: EXPERIMENTAL
Intervention: Uppercase consonant trigrams (e.g., FMH) as primes
Number of subjects: 0
Study 7651811 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple alphabetic decision task (responding only when all characters are letters)
Number of subjects: 0
Study 7651811 — intervention group
Group type: EXPERIMENTAL
Intervention: Varying prime exposure duration
Number of subjects: 0
Study 7651811 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual-matching interpretation ruled out
Number of subjects: 0
Study 2503724 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide and flutamide
Number of subjects: 603
Study 2503724 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide and placebo
Number of subjects: 603
Study 320951 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) at 3.5mg/kg/day and FT‐207 at 8mg/kg/day for 24 to 36 months
Number of subjects: 129
Study 320951 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 129
Study 320951 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) and FT‐207 at the same dose schedule
Number of subjects: 129
Study 30979682 — intervention group
Group type: EXPERIMENTAL
Intervention: LED light mesh sleeping bag
Number of subjects: 2
Study 30979682 — intervention group
Group type: EXPERIMENTAL
Intervention: LED light mesh blanket
Number of subjects: 2
Study 30979682 — intervention group
Group type: COMPARATOR
Intervention: Conventional hospital or ambulatory phototherapy
Number of subjects: 2
Study 31084259 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density lipoprotein (HDL) physiological functions
Number of subjects: 0
Study 31084259 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol efflux capacity and HDL inflammatory index
Number of subjects: 0
Study 28168689 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, moderate intensity physical activity (PA) program (n = 818)
Number of subjects: 635
Study 28168689 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE) program (n = 817)
Number of subjects: 635
Study 25884641 — intervention group
Group type: EXPERIMENTAL
Intervention: Three online formative MCQ tests with automated feedback (E)
Number of subjects: 167
Study 25884641 — intervention group
Group type: COMPARATOR
Intervention: Single paper-based formative MCQ test with face-to-face feedback (C)
Number of subjects: 167
Study 23687226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis
Number of subjects: 0
Study 23687226 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 0
Study 23687226 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinfection plasma LPS levels
Number of subjects: 0
Study 21268722 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (rt-PA) (1 mg in each lumen) once weekly
Number of subjects: 225
Study 21268722 — intervention group
Group type: COMPARATOR
Intervention: Heparin (5000 U per milliliter) three times per week
Number of subjects: 225
Study 19265320 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise for 6 months
Number of subjects: 60
Study 19265320 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 17509249 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic treatment for MS symptoms
Number of subjects: 0
Study 17509249 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatments for MS symptoms
Number of subjects: 0
Study 14763473 — intervention group
Group type: EXPERIMENTAL
Intervention: Management strategies for the ocular surface and tear film before LASIK
Number of subjects: 0
Study 14763473 — intervention group
Group type: EXPERIMENTAL
Intervention: Management strategies during LASIK
Number of subjects: 0
Study 14763473 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term management of the tear film and ocular surface after LASIK
Number of subjects: 0
Study 11795374 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study 9277416 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose atropine (5 micrograms.kg‐.h‐1)
Number of subjects: 6
Study 9277416 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐A receptor antagonist loxiglumide (22 mumol.kg‐.h‐1)
Number of subjects: 6
Study 9277416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 7946858 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron and alfentanil
Number of subjects: 8
Study 7946858 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil alone
Number of subjects: 8
Study 7946858 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron alone
Number of subjects: 8
Study 7946858 — intervention group
Group type: COMPARATOR
Intervention: Placebo and alfentanil
Number of subjects: 8
Study 7946858 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron and placebo
Number of subjects: 8
Study 3278735 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural foods (potato)
Number of subjects: 0
Study 3278735 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural foods (rice and green gram)
Number of subjects: 0
Study 3278735 — intervention group
Group type: COMPARATOR
Intervention: Equivalents (maize flour, casein, maize oil, ispaghula husk)
Number of subjects: 0
Study 28541513 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy training program in adult basic education classrooms
Number of subjects: 23
Study 28541513 — intervention group
Group type: COMPARATOR
Intervention: Standard literacy classes
Number of subjects: 23
Study 28104253 — intervention group
Group type: EXPERIMENTAL
Intervention: Fampridine-SR
Number of subjects: 60
Study 28104253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 26290863 — intervention group
Group type: EXPERIMENTAL
Intervention: LUTS(+)
Number of subjects: 6801
Study 26290863 — intervention group
Group type: COMPARATOR
Intervention: LUTS(-)
Number of subjects: 6801
Study 24119615 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation delivered to the premotor cortex
Number of subjects: 20
Study 24119615 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 21413829 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulbactam-cefoperazone (SC)
Number of subjects: 128
Study 21413829 — intervention group
Group type: COMPARATOR
Intervention: Carbapenems
Number of subjects: 128
Study 19049556 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose CoQ(10)/vitamin E therapy
Number of subjects: 50
Study 19049556 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose CoQ(10)/vitamin E therapy
Number of subjects: 50
Study 16538652 — intervention group
Group type: EXPERIMENTAL
Intervention: Forgiveness training program
Number of subjects: 259
Study 16538652 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 259
Study 12859310 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia (CSA)
Number of subjects: 68
Study 12859310 — intervention group
Group type: COMPARATOR
Intervention: Single-shot spinal anesthesia (SPA)
Number of subjects: 68
Study 11083192 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine-exercise (treadmill exercise during adenosine infusion)
Number of subjects: 793
Study 11083192 — intervention group
Group type: COMPARATOR
Intervention: Adenosine-nonexercise (adenosine infusion alone)
Number of subjects: 793
Study 11083192 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine-exercise
Number of subjects: 793
Study 11083192 — intervention group
Group type: COMPARATOR
Intervention: Adenosine-nonexercise
Number of subjects: 793
Study 9193193 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of d,l-fenfluramine hydrochloride (Pondimin)
Number of subjects: 15
Study 9193193 — intervention group
Group type: COMPARATOR
Intervention: Control group (14 age-matched healthy female controls)
Number of subjects: 15
Study 9193193 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with bulimia nervosa
Number of subjects: 15
Study 8064072 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil (4 mg)
Number of subjects: 24
Study 8064072 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (30 mg)
Number of subjects: 24
Study 8064072 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nedocromil and furosemide
Number of subjects: 24
Study 8064072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3179922 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus methotrexate and vinblastine
Number of subjects: 310
Study 3179922 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 310
Study 3179922 — intervention group
Group type: EXPERIMENTAL
Intervention: FACVP (5‐fluorouracil, doxorubicin, cyclophosphamide, vincristine, and prednisone)
Number of subjects: 310
Study 1163469 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g nitrogen diet
Number of subjects: 6
Study 1163469 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 g nitrogen diet
Number of subjects: 6
Study 1163469 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplement of 0.9 g on the 12 g nitrogen diet
Number of subjects: 6
Study 1163469 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 g nitrogen diet
Number of subjects: 6
Study 1163469 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and protein intake variation
Number of subjects: 6
Study 31076215 — intervention group
Group type: EXPERIMENTAL
Intervention: Benefit-Finding Therapeutic Intervention (BFT)
Number of subjects: 129
Study 31076215 — intervention group
Group type: COMPARATOR
Intervention: Standard Psychoeducation (Control)
Number of subjects: 129